In this view, it is worth noting that the activation of the interferon-indole 2,3-dioxygenase (IDO)-kynurenine axis is common among LN, Down syndrome, and Aicardi–Goutieres syndrome, also associated with clinical neurological manifestations [29,47]. The gene discussed is IDO1; the disease is Aicardi-Goutières syndrome.